Enhancement of perineurial repair and inhibition of nerve adhesion by viscous injectable pure alginate sol

Clinical treatment of recurrent symptoms following peripheral nerve decompression is problematic. Removal of scar tissue can produce an inappropriately pronounced healing response and thereby lead to more serious tethering or compression of the nerve. The goal of the present study was to test the ab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Plastic and reconstructive surgery (1963) 2005-09, Vol.116 (3), p.823-830
Hauptverfasser: OHSUMI, Hidehiko, HIRATA, Hitoshi, NAGAKURA, Takeshi, TSUJII, Masaya, SUGIMOTO, Toshiko, MIYAMOTO, Keiichi, HORIUCHI, Takashi, NAGAO, Masahiro, NAKASHIMA, Toshihide, UCHIDA, Atsumasa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 830
container_issue 3
container_start_page 823
container_title Plastic and reconstructive surgery (1963)
container_volume 116
creator OHSUMI, Hidehiko
HIRATA, Hitoshi
NAGAKURA, Takeshi
TSUJII, Masaya
SUGIMOTO, Toshiko
MIYAMOTO, Keiichi
HORIUCHI, Takashi
NAGAO, Masahiro
NAKASHIMA, Toshihide
UCHIDA, Atsumasa
description Clinical treatment of recurrent symptoms following peripheral nerve decompression is problematic. Removal of scar tissue can produce an inappropriately pronounced healing response and thereby lead to more serious tethering or compression of the nerve. The goal of the present study was to test the ability of viscous injectable pure alginate sol to prevent perineurial adhesion using a rat neurolysis model. The antiadhesive effect of viscous injectable pure alginate sol after neurolysis was evaluated histologically and biomechanically. A total of 40 rats were used in this study. The viscous injectable pure alginate sol was applied topically on the right side after external (six rats) or extensive internal (six rats) neurolysis, whereas the left side received no treatment. The nerves were harvested over 6 weeks, and histologic analysis was performed with hematoxylin and eosin staining and Masson trichrome staining. Functional analysis of the blood and perineurial barriers was also evaluated with Evans blue albumin (four rats). Sixteen rats were used for biomechanical analysis, and eight rats were used as a control group. The results were analyzed statistically using a post hoc test. Histologic examination showed that the use of viscous injectable pure alginate sol was associated with excellent biocompatibility and strong inhibition of perineurial granulation. Viscous injectable pure alginate sol was absorbed completely within 6 weeks without inducing inflammation. In addition, viscous injectable pure alginate sol enhanced repair of the perineurium associated with regeneration of epithelial-like cell layers, a key structure necessary for barrier function of the inner layer of the perineurium. Functional analysis with Evans blue albumin clearly demonstrated that, although blood nerve barrier function recovered by 6 weeks postoperatively in all nerves, the perineurial barrier function recovered only in the sol-treated nerves. Biomechanical study showed a significant antiadhesive effect of viscous injectable pure alginate sol. Viscous injectable pure alginate sol inhibited adhesion formation around nerves and enhanced regeneration of the perineurium with barrier function. Because excessive perineurial fibrosis and tethering at the neurolysis or neurorrhaphy site is a common postoperative problem in peripheral nerve surgery, viscous injectable pure alginate sol appears to have potentially broad clinical applications.
doi_str_mv 10.1097/01.prs.0000176893.44656.8e
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68556602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68556602</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-f758a2688ddd53bf8055050b8e72c5945a8602614fcebbdb8980707e3436bb073</originalsourceid><addsrcrecordid>eNpFkEtr3DAQgEVoSLZJ_kIRhfZmV2_JvZWQNoGFXpKzkOxxVotXdiU7sP8-crOwcxkYvnl9CH2lpKak0T8IraeUa1KCamUaXguhpKoNXKANlaypBBPsE9oQwllFiWTX6HPO-xXnSl6ha6qooIaxDdo_xJ2LLRwgznjs8QQpRFhScANOMLmQsIsdDnEXfJjDGFcoQnoD7Lod5LXij_gt5HZccuH20M7OD4CnJRVmeA3RzYDzONyiy94NGe5O-Qa9_H54vn-stn__PN3_2latoHyuei2NY8qYrusk970hUhJJvAHNWtkI6YwirDzQt-B9501jiCYauODKe6L5Dfr-MXdK478F8mwP5ToYBheh3GiVkVKVEQX8-QG2acw5QW-nFA4uHS0ldjVtCS2lbM-m7X_T1kBp_nLasvgDdOfWk9oCfDsBLrdu6FPRHPKZ05RqwwR_ByBGiU4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68556602</pqid></control><display><type>article</type><title>Enhancement of perineurial repair and inhibition of nerve adhesion by viscous injectable pure alginate sol</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>OHSUMI, Hidehiko ; HIRATA, Hitoshi ; NAGAKURA, Takeshi ; TSUJII, Masaya ; SUGIMOTO, Toshiko ; MIYAMOTO, Keiichi ; HORIUCHI, Takashi ; NAGAO, Masahiro ; NAKASHIMA, Toshihide ; UCHIDA, Atsumasa</creator><creatorcontrib>OHSUMI, Hidehiko ; HIRATA, Hitoshi ; NAGAKURA, Takeshi ; TSUJII, Masaya ; SUGIMOTO, Toshiko ; MIYAMOTO, Keiichi ; HORIUCHI, Takashi ; NAGAO, Masahiro ; NAKASHIMA, Toshihide ; UCHIDA, Atsumasa</creatorcontrib><description>Clinical treatment of recurrent symptoms following peripheral nerve decompression is problematic. Removal of scar tissue can produce an inappropriately pronounced healing response and thereby lead to more serious tethering or compression of the nerve. The goal of the present study was to test the ability of viscous injectable pure alginate sol to prevent perineurial adhesion using a rat neurolysis model. The antiadhesive effect of viscous injectable pure alginate sol after neurolysis was evaluated histologically and biomechanically. A total of 40 rats were used in this study. The viscous injectable pure alginate sol was applied topically on the right side after external (six rats) or extensive internal (six rats) neurolysis, whereas the left side received no treatment. The nerves were harvested over 6 weeks, and histologic analysis was performed with hematoxylin and eosin staining and Masson trichrome staining. Functional analysis of the blood and perineurial barriers was also evaluated with Evans blue albumin (four rats). Sixteen rats were used for biomechanical analysis, and eight rats were used as a control group. The results were analyzed statistically using a post hoc test. Histologic examination showed that the use of viscous injectable pure alginate sol was associated with excellent biocompatibility and strong inhibition of perineurial granulation. Viscous injectable pure alginate sol was absorbed completely within 6 weeks without inducing inflammation. In addition, viscous injectable pure alginate sol enhanced repair of the perineurium associated with regeneration of epithelial-like cell layers, a key structure necessary for barrier function of the inner layer of the perineurium. Functional analysis with Evans blue albumin clearly demonstrated that, although blood nerve barrier function recovered by 6 weeks postoperatively in all nerves, the perineurial barrier function recovered only in the sol-treated nerves. Biomechanical study showed a significant antiadhesive effect of viscous injectable pure alginate sol. Viscous injectable pure alginate sol inhibited adhesion formation around nerves and enhanced regeneration of the perineurium with barrier function. Because excessive perineurial fibrosis and tethering at the neurolysis or neurorrhaphy site is a common postoperative problem in peripheral nerve surgery, viscous injectable pure alginate sol appears to have potentially broad clinical applications.</description><identifier>ISSN: 0032-1052</identifier><identifier>EISSN: 1529-4242</identifier><identifier>DOI: 10.1097/01.prs.0000176893.44656.8e</identifier><identifier>PMID: 16141822</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Alginates - administration &amp; dosage ; Alginates - pharmacology ; Alginates - therapeutic use ; Animals ; Biocompatible Materials - administration &amp; dosage ; Biocompatible Materials - pharmacology ; Biocompatible Materials - therapeutic use ; Biological and medical sciences ; Blood-Nerve Barrier - physiology ; Evans Blue ; Glucuronic Acid - administration &amp; dosage ; Glucuronic Acid - pharmacology ; Glucuronic Acid - therapeutic use ; Hexuronic Acids - administration &amp; dosage ; Hexuronic Acids - pharmacology ; Hexuronic Acids - therapeutic use ; Injections ; Medical sciences ; Nerve Regeneration - drug effects ; Peripheral Nerves - surgery ; Rats ; Rats, Inbred Lew ; Recovery of Function ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tissue Adhesions - prevention &amp; control</subject><ispartof>Plastic and reconstructive surgery (1963), 2005-09, Vol.116 (3), p.823-830</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-f758a2688ddd53bf8055050b8e72c5945a8602614fcebbdb8980707e3436bb073</citedby><cites>FETCH-LOGICAL-c413t-f758a2688ddd53bf8055050b8e72c5945a8602614fcebbdb8980707e3436bb073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17117824$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16141822$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OHSUMI, Hidehiko</creatorcontrib><creatorcontrib>HIRATA, Hitoshi</creatorcontrib><creatorcontrib>NAGAKURA, Takeshi</creatorcontrib><creatorcontrib>TSUJII, Masaya</creatorcontrib><creatorcontrib>SUGIMOTO, Toshiko</creatorcontrib><creatorcontrib>MIYAMOTO, Keiichi</creatorcontrib><creatorcontrib>HORIUCHI, Takashi</creatorcontrib><creatorcontrib>NAGAO, Masahiro</creatorcontrib><creatorcontrib>NAKASHIMA, Toshihide</creatorcontrib><creatorcontrib>UCHIDA, Atsumasa</creatorcontrib><title>Enhancement of perineurial repair and inhibition of nerve adhesion by viscous injectable pure alginate sol</title><title>Plastic and reconstructive surgery (1963)</title><addtitle>Plast Reconstr Surg</addtitle><description>Clinical treatment of recurrent symptoms following peripheral nerve decompression is problematic. Removal of scar tissue can produce an inappropriately pronounced healing response and thereby lead to more serious tethering or compression of the nerve. The goal of the present study was to test the ability of viscous injectable pure alginate sol to prevent perineurial adhesion using a rat neurolysis model. The antiadhesive effect of viscous injectable pure alginate sol after neurolysis was evaluated histologically and biomechanically. A total of 40 rats were used in this study. The viscous injectable pure alginate sol was applied topically on the right side after external (six rats) or extensive internal (six rats) neurolysis, whereas the left side received no treatment. The nerves were harvested over 6 weeks, and histologic analysis was performed with hematoxylin and eosin staining and Masson trichrome staining. Functional analysis of the blood and perineurial barriers was also evaluated with Evans blue albumin (four rats). Sixteen rats were used for biomechanical analysis, and eight rats were used as a control group. The results were analyzed statistically using a post hoc test. Histologic examination showed that the use of viscous injectable pure alginate sol was associated with excellent biocompatibility and strong inhibition of perineurial granulation. Viscous injectable pure alginate sol was absorbed completely within 6 weeks without inducing inflammation. In addition, viscous injectable pure alginate sol enhanced repair of the perineurium associated with regeneration of epithelial-like cell layers, a key structure necessary for barrier function of the inner layer of the perineurium. Functional analysis with Evans blue albumin clearly demonstrated that, although blood nerve barrier function recovered by 6 weeks postoperatively in all nerves, the perineurial barrier function recovered only in the sol-treated nerves. Biomechanical study showed a significant antiadhesive effect of viscous injectable pure alginate sol. Viscous injectable pure alginate sol inhibited adhesion formation around nerves and enhanced regeneration of the perineurium with barrier function. Because excessive perineurial fibrosis and tethering at the neurolysis or neurorrhaphy site is a common postoperative problem in peripheral nerve surgery, viscous injectable pure alginate sol appears to have potentially broad clinical applications.</description><subject>Alginates - administration &amp; dosage</subject><subject>Alginates - pharmacology</subject><subject>Alginates - therapeutic use</subject><subject>Animals</subject><subject>Biocompatible Materials - administration &amp; dosage</subject><subject>Biocompatible Materials - pharmacology</subject><subject>Biocompatible Materials - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood-Nerve Barrier - physiology</subject><subject>Evans Blue</subject><subject>Glucuronic Acid - administration &amp; dosage</subject><subject>Glucuronic Acid - pharmacology</subject><subject>Glucuronic Acid - therapeutic use</subject><subject>Hexuronic Acids - administration &amp; dosage</subject><subject>Hexuronic Acids - pharmacology</subject><subject>Hexuronic Acids - therapeutic use</subject><subject>Injections</subject><subject>Medical sciences</subject><subject>Nerve Regeneration - drug effects</subject><subject>Peripheral Nerves - surgery</subject><subject>Rats</subject><subject>Rats, Inbred Lew</subject><subject>Recovery of Function</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tissue Adhesions - prevention &amp; control</subject><issn>0032-1052</issn><issn>1529-4242</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtr3DAQgEVoSLZJ_kIRhfZmV2_JvZWQNoGFXpKzkOxxVotXdiU7sP8-crOwcxkYvnl9CH2lpKak0T8IraeUa1KCamUaXguhpKoNXKANlaypBBPsE9oQwllFiWTX6HPO-xXnSl6ha6qooIaxDdo_xJ2LLRwgznjs8QQpRFhScANOMLmQsIsdDnEXfJjDGFcoQnoD7Lod5LXij_gt5HZccuH20M7OD4CnJRVmeA3RzYDzONyiy94NGe5O-Qa9_H54vn-stn__PN3_2latoHyuei2NY8qYrusk970hUhJJvAHNWtkI6YwirDzQt-B9501jiCYauODKe6L5Dfr-MXdK478F8mwP5ToYBheh3GiVkVKVEQX8-QG2acw5QW-nFA4uHS0ldjVtCS2lbM-m7X_T1kBp_nLasvgDdOfWk9oCfDsBLrdu6FPRHPKZ05RqwwR_ByBGiU4</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>OHSUMI, Hidehiko</creator><creator>HIRATA, Hitoshi</creator><creator>NAGAKURA, Takeshi</creator><creator>TSUJII, Masaya</creator><creator>SUGIMOTO, Toshiko</creator><creator>MIYAMOTO, Keiichi</creator><creator>HORIUCHI, Takashi</creator><creator>NAGAO, Masahiro</creator><creator>NAKASHIMA, Toshihide</creator><creator>UCHIDA, Atsumasa</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>Enhancement of perineurial repair and inhibition of nerve adhesion by viscous injectable pure alginate sol</title><author>OHSUMI, Hidehiko ; HIRATA, Hitoshi ; NAGAKURA, Takeshi ; TSUJII, Masaya ; SUGIMOTO, Toshiko ; MIYAMOTO, Keiichi ; HORIUCHI, Takashi ; NAGAO, Masahiro ; NAKASHIMA, Toshihide ; UCHIDA, Atsumasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-f758a2688ddd53bf8055050b8e72c5945a8602614fcebbdb8980707e3436bb073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Alginates - administration &amp; dosage</topic><topic>Alginates - pharmacology</topic><topic>Alginates - therapeutic use</topic><topic>Animals</topic><topic>Biocompatible Materials - administration &amp; dosage</topic><topic>Biocompatible Materials - pharmacology</topic><topic>Biocompatible Materials - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood-Nerve Barrier - physiology</topic><topic>Evans Blue</topic><topic>Glucuronic Acid - administration &amp; dosage</topic><topic>Glucuronic Acid - pharmacology</topic><topic>Glucuronic Acid - therapeutic use</topic><topic>Hexuronic Acids - administration &amp; dosage</topic><topic>Hexuronic Acids - pharmacology</topic><topic>Hexuronic Acids - therapeutic use</topic><topic>Injections</topic><topic>Medical sciences</topic><topic>Nerve Regeneration - drug effects</topic><topic>Peripheral Nerves - surgery</topic><topic>Rats</topic><topic>Rats, Inbred Lew</topic><topic>Recovery of Function</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tissue Adhesions - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OHSUMI, Hidehiko</creatorcontrib><creatorcontrib>HIRATA, Hitoshi</creatorcontrib><creatorcontrib>NAGAKURA, Takeshi</creatorcontrib><creatorcontrib>TSUJII, Masaya</creatorcontrib><creatorcontrib>SUGIMOTO, Toshiko</creatorcontrib><creatorcontrib>MIYAMOTO, Keiichi</creatorcontrib><creatorcontrib>HORIUCHI, Takashi</creatorcontrib><creatorcontrib>NAGAO, Masahiro</creatorcontrib><creatorcontrib>NAKASHIMA, Toshihide</creatorcontrib><creatorcontrib>UCHIDA, Atsumasa</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Plastic and reconstructive surgery (1963)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OHSUMI, Hidehiko</au><au>HIRATA, Hitoshi</au><au>NAGAKURA, Takeshi</au><au>TSUJII, Masaya</au><au>SUGIMOTO, Toshiko</au><au>MIYAMOTO, Keiichi</au><au>HORIUCHI, Takashi</au><au>NAGAO, Masahiro</au><au>NAKASHIMA, Toshihide</au><au>UCHIDA, Atsumasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancement of perineurial repair and inhibition of nerve adhesion by viscous injectable pure alginate sol</atitle><jtitle>Plastic and reconstructive surgery (1963)</jtitle><addtitle>Plast Reconstr Surg</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>116</volume><issue>3</issue><spage>823</spage><epage>830</epage><pages>823-830</pages><issn>0032-1052</issn><eissn>1529-4242</eissn><abstract>Clinical treatment of recurrent symptoms following peripheral nerve decompression is problematic. Removal of scar tissue can produce an inappropriately pronounced healing response and thereby lead to more serious tethering or compression of the nerve. The goal of the present study was to test the ability of viscous injectable pure alginate sol to prevent perineurial adhesion using a rat neurolysis model. The antiadhesive effect of viscous injectable pure alginate sol after neurolysis was evaluated histologically and biomechanically. A total of 40 rats were used in this study. The viscous injectable pure alginate sol was applied topically on the right side after external (six rats) or extensive internal (six rats) neurolysis, whereas the left side received no treatment. The nerves were harvested over 6 weeks, and histologic analysis was performed with hematoxylin and eosin staining and Masson trichrome staining. Functional analysis of the blood and perineurial barriers was also evaluated with Evans blue albumin (four rats). Sixteen rats were used for biomechanical analysis, and eight rats were used as a control group. The results were analyzed statistically using a post hoc test. Histologic examination showed that the use of viscous injectable pure alginate sol was associated with excellent biocompatibility and strong inhibition of perineurial granulation. Viscous injectable pure alginate sol was absorbed completely within 6 weeks without inducing inflammation. In addition, viscous injectable pure alginate sol enhanced repair of the perineurium associated with regeneration of epithelial-like cell layers, a key structure necessary for barrier function of the inner layer of the perineurium. Functional analysis with Evans blue albumin clearly demonstrated that, although blood nerve barrier function recovered by 6 weeks postoperatively in all nerves, the perineurial barrier function recovered only in the sol-treated nerves. Biomechanical study showed a significant antiadhesive effect of viscous injectable pure alginate sol. Viscous injectable pure alginate sol inhibited adhesion formation around nerves and enhanced regeneration of the perineurium with barrier function. Because excessive perineurial fibrosis and tethering at the neurolysis or neurorrhaphy site is a common postoperative problem in peripheral nerve surgery, viscous injectable pure alginate sol appears to have potentially broad clinical applications.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>16141822</pmid><doi>10.1097/01.prs.0000176893.44656.8e</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0032-1052
ispartof Plastic and reconstructive surgery (1963), 2005-09, Vol.116 (3), p.823-830
issn 0032-1052
1529-4242
language eng
recordid cdi_proquest_miscellaneous_68556602
source MEDLINE; Journals@Ovid Complete
subjects Alginates - administration & dosage
Alginates - pharmacology
Alginates - therapeutic use
Animals
Biocompatible Materials - administration & dosage
Biocompatible Materials - pharmacology
Biocompatible Materials - therapeutic use
Biological and medical sciences
Blood-Nerve Barrier - physiology
Evans Blue
Glucuronic Acid - administration & dosage
Glucuronic Acid - pharmacology
Glucuronic Acid - therapeutic use
Hexuronic Acids - administration & dosage
Hexuronic Acids - pharmacology
Hexuronic Acids - therapeutic use
Injections
Medical sciences
Nerve Regeneration - drug effects
Peripheral Nerves - surgery
Rats
Rats, Inbred Lew
Recovery of Function
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Tissue Adhesions - prevention & control
title Enhancement of perineurial repair and inhibition of nerve adhesion by viscous injectable pure alginate sol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A52%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancement%20of%20perineurial%20repair%20and%20inhibition%20of%20nerve%20adhesion%20by%20viscous%20injectable%20pure%20alginate%20sol&rft.jtitle=Plastic%20and%20reconstructive%20surgery%20(1963)&rft.au=OHSUMI,%20Hidehiko&rft.date=2005-09-01&rft.volume=116&rft.issue=3&rft.spage=823&rft.epage=830&rft.pages=823-830&rft.issn=0032-1052&rft.eissn=1529-4242&rft_id=info:doi/10.1097/01.prs.0000176893.44656.8e&rft_dat=%3Cproquest_cross%3E68556602%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68556602&rft_id=info:pmid/16141822&rfr_iscdi=true